Outcome of second- and third-line Helicobacter pylori eradication therapies based on antimicrobial susceptibility testing.
about
Treatment of Helicobacter pylori infection 2016.Importance of antimicrobial susceptibility testing for the management of eradication in Helicobacter pylori infection.Efficacy and safety of sequential versus quadruple therapy as second-line treatment for helicobacter pylori infection-A randomized controlled trial
P2860
Outcome of second- and third-line Helicobacter pylori eradication therapies based on antimicrobial susceptibility testing.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Outcome of second- and third-l ...... robial susceptibility testing.
@en
type
label
Outcome of second- and third-l ...... robial susceptibility testing.
@en
prefLabel
Outcome of second- and third-l ...... robial susceptibility testing.
@en
P2093
P2860
P356
P1476
Outcome of second- and third-l ...... robial susceptibility testing.
@en
P2093
Erik-Oliver Glocker
Manfred Kist
Nicole Wüppenhorst
Sarah Draeger
P2860
P304
P356
10.1093/JAC/DKV223
P407
P577
2015-08-05T00:00:00Z